Growth Metrics

GoodRx Holdings (GDRX) Assets Average (2020 - 2025)

GoodRx Holdings' Assets Average history spans 5 years, with the latest figure at $1.4 billion for Q4 2024.

  • For Q4 2024, Assets Average fell 16.8% year-over-year to $1.4 billion; the TTM value through Dec 2024 reached $1.4 billion, down 16.8%, while the annual FY2024 figure was $1.5 billion, 6.78% down from the prior year.
  • Assets Average for Q4 2024 was $1.4 billion at GoodRx Holdings, down from $1.4 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.7 billion in Q3 2023 and bottomed at $1.4 billion in Q4 2024.
  • The 5-year median for Assets Average is $1.6 billion (2022), against an average of $1.6 billion.
  • The largest annual shift saw Assets Average rose 7.63% in 2023 before it fell 16.8% in 2024.
  • A 5-year view of Assets Average shows it stood at $1.5 billion in 2020, then grew by 6.8% to $1.6 billion in 2021, then fell by 1.56% to $1.6 billion in 2022, then increased by 3.94% to $1.6 billion in 2023, then dropped by 16.8% to $1.4 billion in 2024.
  • Per Business Quant, the three most recent readings for GDRX's Assets Average are $1.4 billion (Q4 2024), $1.4 billion (Q3 2024), and $1.5 billion (Q2 2024).